Similar articles

• Relapse in chronic schizophrenics treated with fluphenazine decanoate is associated with low serum neuroleptic levels.

  Jayaram G, Coyle J, Tune L. Jayaram G, et al. J Clin Psychiatry. 1986 May;47(5):247-8. J Clin Psychiatry. 1986. PMID: 3700342
• Fluphenazine decanoate, oral fluphenazine, and placebo in the treatment of remitted schizophrenics. II. Rating scale data [proceedings].

  Rifkin A, Quitkin F, Kane J, Klein DF. Rifkin A, et al. Psychopharmacol Bull. 1977 Apr;13(2):49-50. Psychopharmacol Bull. 1977. PMID: 323910 Clinical Trial. No abstract available.
• Comparison of fluphenazine decanoate, oral fluphenazine, and placebo in remitted outpatient schizophrenics.

  Rifkin A, Quitkin F, Rabiner CJ, Klein DF. Rifkin A, et al. Psychopharmacol Bull. 1976 Apr;12(2):24-6. Psychopharmacol Bull. 1976. PMID: 769022 Clinical Trial. No abstract available.
• The social value of fluphenazine decanoate.

  Stevens B. Stevens B. Acta Psychiatr Belg. 1976 Sep-Oct;76(5):792-804. Acta Psychiatr Belg. 1976. PMID: 799897 Review.
• The use of depot neuroleptics: clinical experience in the United States.

  Kane JM. Kane JM. J Clin Psychiatry. 1984 May;45(5 Pt 2):5-12. J Clin Psychiatry. 1984. PMID: 6370987 Review.